St. Luke’s Medical Center Selects Allscripts Sunrise™
July 16 2019 - 8:01AM
Business Wire
Allscripts client in Philippines to provide
first-of-its-kind acute care services
St. Luke’s Medical Center, located in the Philippines, has
selected Allscripts (NASDAQ: MDRX) Sunrise™ Acute Care as its
electronic health record (EHR) to achieve the goal of
standardization across its facilities via a single, integrated EHR.
St. Luke’s Medical Center further represents the company’s growing
momentum in territories outside of the United States.
St. Luke’s Medical Center is recognized as the leading and most
respected healthcare institution in the Philippines, having a total
of 1,146 rooms with its Quezon City and Global City sites. A
testament to St. Luke's world-class quality medical service is its
accreditation with prestigious international organizations. One of
which is the Joint Commission International-- the recognized leader
in international healthcare accreditation. It is the most reliable
accrediting body in the medical field that evaluates institutions
outside the United States, based on stringent evidence-based global
standards. St. Luke’s Quezon City became the first JCI-accredited
hospital in the Philippines in 2003. In 2016, it also became the
first JCI-accredited academic medical center in the country. St.
Luke’s Global City, on the other hand, was granted the JCI
accreditation in 2012.
“Our goal in St. Luke’s is to continuously strive to improve the
patient experience and the delivery of high-quality healthcare. We
aim to maintain our gold standard of global healthcare.
Implementing Allscripts Sunrise EHR will help us achieve this goal
by providing a single patient record with standardized data," said
President and CEO Dr. Arturo De La Peña. “In addition, we believe
Allscripts Sunrise will help elevate the medical center to the
HIMSS EMRAM digital maturity model, significantly improving the
quality of care we provide.”
Used by healthcare organizations across the globe, Allscripts
Sunrise is an integrated electronic health record that connects all
aspects of care, including ambulatory, surgical, radiology and
laboratory services. Built to enable efficient and safe care,
Sunrise is a clinician-friendly, evidence-based single platform
with integrated analytics that helps deliver true personalized
medicine. Sunrise supports all core care venues across the
enterprise by delivering a single patient record, and features
patient-centric capabilities that increase access and convenience
for the consumer.
"St. Luke’s is fully committed to delivering the highest quality
health care in the Philippines, and we are eager to help improve
the experience for the hospital, clinicians and patients with a
single patient record and streamlined workflows,” said Rohan Ward,
Allscripts General Manager, Asia.
About Allscripts Allscripts (NASDAQ: MDRX) is a leader in
healthcare information technology solutions that advance clinical,
financial and operational results. Our innovative solutions connect
people, places and data across an Open, Connected Community of
Health™. Connectivity empowers caregivers to make better decisions
and deliver better care for healthier populations. To learn more,
visit www.allscripts.com, Twitter, YouTube and
It Takes A Community: The Allscripts Blog.
© 2019 Allscripts Healthcare, LLC and/or its affiliates. All
Rights Reserved.
Allscripts, the Allscripts logo, and other Allscripts marks are
trademarks of Allscripts Healthcare, LLC and/or its affiliates. All
other products are trademarks of their respective holders, all
rights reserved. Reference to these products is not intended to
imply affiliation with or sponsorship of Allscripts Healthcare, LLC
and/or its affiliates.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20190716005300/en/
For more information contact: Investors: Stephen Shulstein 312-386-6735
Stephen.Shulstein@allscripts.com
Media: Concetta Rasiarmos
312-447-2466 concetta.rasiarmos@allscripts.com
Veradigm (NASDAQ:MDRX)
Historical Stock Chart
From Mar 2024 to Apr 2024
Veradigm (NASDAQ:MDRX)
Historical Stock Chart
From Apr 2023 to Apr 2024